The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases
- PMID: 29773066
- DOI: 10.2174/1568026618666180518101028
The Development of New Small-Molecule Inhibitors Targeting Bacterial Metallo-β-lactamases
Abstract
Metallo-β-lactamases (MBLs) are a family of Zn(II)-dependent enzymes that can hydrolyze almost all β-lactam antibiotics. Horizontal transfer of the genes encoding MBLs among Gram-negative bacteria pathogens has led to the emergence of extensively drug-resistant pathogens, which now represent a major threat to human health. As there is not to date yet a clinically available MBL inhibitor, the discovery of new MBL inhibitors has great urgency. This review highlights the recent developments in the discovery of small-molecule MBL inhibitors.
Keywords: Metallo-β-lactamases; cyclic Boronates; dicarboxylic acid derivatives; natural products; peptide inhibitors; thiol derivatives; triazoles..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
